{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:24:43Z","timestamp":1792801483237,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.expneurol.2011.05.024","type":"journal-article","created":{"date-parts":[[2011,6,24]],"date-time":"2011-06-24T07:06:05Z","timestamp":1308899165000},"page":"127-134","source":"Crossref","is-referenced-by-count":60,"title":["Bioenergetic dysfunction in Huntington's disease human cybrids"],"prefix":"10.1016","volume":"231","author":[{"given":"I. Luisa","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Cunha-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Teresa","family":"Proen\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Janu\u00e1rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina R.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Cristina","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.05.024_bb0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2008.07.009","article-title":"Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients","volume":"374","author":"Almeida","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0010","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410430321","article-title":"Complex I defect in muscle from patients with Huntington's disease","volume":"43","author":"Arenas","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0015","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.E05-07-0607","article-title":"Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin","volume":"17","author":"Benchoua","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.expneurol.2011.05.024_bb0020","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bbrc.2004.08.035","article-title":"Deranged neuronal calcium signaling and Huntington disease","volume":"322","author":"Bezprozvanny","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0025","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tins.2008.09.004","article-title":"Mutant huntingtin and mitochondrial dysfunction","volume":"31","author":"Bossy-Wetzel","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","article-title":"Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia","volume":"41","author":"Browne","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1471-4159.1996.66010403.x","article-title":"A reevaluation of the role of mitochondria in neuronal Ca2+ homeostasis","volume":"66","author":"Budd","year":"1996","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-510X(85)90112-1","article-title":"Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gammaglutamyl transpeptidase in post-mortem brain from Huntington's disease and agonal cases","volume":"67","author":"Butterworth","year":"1985","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","article-title":"Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release","volume":"13","author":"Choo","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2005.05.065","article-title":"Increased glutathione levels in cortical and striatal mitochondria of the R6\/2 Huntington's disease mouse model","volume":"386","author":"Choo","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0055","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/sj.cdd.4401967","article-title":"Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects","volume":"13","author":"Ciammola","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0060","doi-asserted-by":"crossref","first-page":"7961","DOI":"10.1016\/S0021-9258(19)40801-6","article-title":"Metabolic implications of the distribution of the alanine aminotransferase isoenzymes","volume":"250","author":"DeRosa","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2010.01.002","article-title":"Mitochondrial-dependent apoptosis in Huntington's disease human cybrids","volume":"222","author":"Ferreira","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0197-0186(99)00114-X","article-title":"The alpha-ketoglutarate dehydrogenase complex in neurodegeneration","volume":"36","author":"Gibson","year":"2000","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1385\/MN:31:1-3:043","article-title":"The alpha-ketoglutarate-dehydrogenase complex: a mediator between mitochondria and oxidative stress in neurodegeneration","volume":"31","author":"Gibson","year":"2005","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0080","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1111\/j.1460-9568.2008.06310.x","article-title":"Mechanisms of neurodegeneration in Huntington's disease","volume":"27","author":"Gil","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0090","series-title":"Methods of Enzymatic Analysis","first-page":"507","article-title":"Creatine phosphate","author":"Heinz","year":"1985"},{"key":"10.1016\/j.expneurol.2011.05.024_bb0095","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.05.024_bb0100","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0105","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1126\/science.2814477","article-title":"Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation","volume":"246","author":"King","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.05.024_bb0110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","article-title":"Energy metabolism defects in Huntington's disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0115","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","article-title":"Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy","volume":"48","author":"Lodi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jnr.20293","article-title":"Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress","volume":"79","author":"Martin","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0125","doi-asserted-by":"crossref","first-page":"23357","DOI":"10.1074\/jbc.M100320200","article-title":"Modulation of mitochondrial function by hydrogen peroxide","volume":"276","author":"Nulton-Persson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0130","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1111\/j.1742-4658.2008.06612.x","article-title":"Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice","volume":"275","author":"Olah","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2010.06741.x","article-title":"Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum","volume":"114","author":"Oliveira","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0140","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","article-title":"Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors","volume":"26","author":"Oliveira","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0145","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0150","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1212\/WNL.40.8.1231","article-title":"Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease","volume":"40","author":"Parker","year":"1990","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.05.024_bb0155","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol. Cell. Proteomics."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nbd.2007.04.008","article-title":"Normal platelet mitochondrial complex I activity in Huntington's disease","volume":"27","author":"Powers","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0165","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0609833104","article-title":"Selective defect of in vivo glycolysis in early Huntington's disease striatum","volume":"104","author":"Powers","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.expneurol.2011.05.024_bb0170","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.cdd.4400916","article-title":"The mechanism of mitochondrial membrane potential retention following release of cytochrome c in apoptotic GT1-7 neural cells","volume":"8","author":"Rego","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0175","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1523\/JNEUROSCI.21-06-01893.2001","article-title":"Mitochondria control ampa\/kainate receptor-induced cytoplasmic calcium deregulation in rat cerebellar granule cells","volume":"21","author":"Rego","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0180","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2174\/1389450111007011218","article-title":"Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease \u2014 from clinical features to the bench","volume":"11","author":"Rosenstock","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.expneurol.2011.05.024_bb0185","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mds.20373","article-title":"Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease","volume":"20","author":"Saft","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0190","series-title":"Medical Biochemistry at a Glance 2nd Edition","author":"Salway","year":"2006"},{"key":"10.1016\/j.expneurol.2011.05.024_bb0195","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","article-title":"Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization","volume":"5","author":"Sawa","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0005-2728(98)00115-7","article-title":"Mitochondrial dysfunction in neurodegenerative disorders","volume":"1366","author":"Schapira","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2011.05.024_bb0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410130116","article-title":"Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain","volume":"13","author":"Sorbi","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0210","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1523\/JNEUROSCI.1899-04.2004","article-title":"Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species","volume":"24","author":"Starkov","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0215","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0003-2697(85)90405-1","article-title":"Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells","volume":"146","author":"Stocchi","year":"1985","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0220","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/bbrc.1999.1095","article-title":"Characterization of cybrid cell lines containing mtDNA from Huntington's disease patients","volume":"261","author":"Swerdlow","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0230","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/mds.21540","article-title":"Clinical correlates of mitochondrial function in Huntington's disease muscle","volume":"22","author":"Turner","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ab.2004.10.020","article-title":"Determination of oxidized and reduced nicotinamide adenine dinucleotide in cell monolayers using a single extraction procedure and a spectrophotometric assay","volume":"338","author":"Umemura","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0240","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/hmg\/ddn404","article-title":"Effects of overexpression of huntingtin proteins on mitochondrial integrity","volume":"18","author":"Wang","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0245","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0021-9258(18)64988-9","article-title":"Localization of the primary metabolic block produced by 2-deoxyglucose","volume":"224","author":"Wick","year":"1957","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.05.024_bb0250","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1471-4159.2007.04957.x","article-title":"c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons","volume":"104","author":"Zhou","year":"2008","journal-title":"J. Neurochem."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611002214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611002214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T19:40:50Z","timestamp":1712518850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611002214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0014488611002214"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.05.024","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}